Evidence map›Paper›PMID 34519843›Full record

ArticleInternational urogynecology journal2022

Efficacy and patient acceptability of the continence dish.

Kate H Moore, Wendy Allen, Katrina Parkin, Fiona Beaupeurt, Chris Chan, Zhuoran Chen

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International urogynecology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kate H MooreThe Pelvic Floor Unit, Department of Urogynaecology, University of New South Wales at St. George Hospital, Gray Street, Kogarah, Sydney, NSW, 2217, Australia. k.moore@unsw.edu.au.ORCID http://orcid.org/0000-0001-6947-9839
Wendy AllenThe Pelvic Floor Unit, Department of Urogynaecology, University of New South Wales at St. George Hospital, Gray Street, Kogarah, Sydney, NSW, 2217, Australia.
Katrina ParkinThe Pelvic Floor Unit, Department of Urogynaecology, University of New South Wales at St. George Hospital, Gray Street, Kogarah, Sydney, NSW, 2217, Australia.
Fiona BeaupeurtThe Pelvic Floor Unit, Department of Urogynaecology, University of New South Wales at St. George Hospital, Gray Street, Kogarah, Sydney, NSW, 2217, Australia.
Chris ChanThe Pelvic Floor Unit, Department of Urogynaecology, University of New South Wales at St. George Hospital, Gray Street, Kogarah, Sydney, NSW, 2217, Australia.
Zhuoran ChenThe Pelvic Floor Unit, Department of Urogynaecology, University of New South Wales at St. George Hospital, Gray Street, Kogarah, Sydney, NSW, 2217, Australia.
UNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and hypothesisThe continence dish has been a treatment option since 2002 for women with stress urinary incontinence (SUI) who decline surgery, but few quantitative objective efficacy data are published. We aimed to determine the efficacy and acceptability of this device for pure SUI or mixed incontinence (MUI).

methodsProspective interventional cohort study of 100 women with SUI or stress-predominant MUI who were interested to use the device; International Consultation on Incontinence Questionnaire (ICIQ) was primary outcome measure; 24-h pad test and Incontinence Impact Questionnaire (IIQ) were secondary outcomes. Acceptability was determined by device retention for 4 weeks, adverse events and ability to self-insert the device.

resultsOf 100 suitable women, 9 were not actually fitted, and 27 did not complete (acceptability: 64/100). The rate of adverse events was 7.7%, with 62.5% of users able to self-insert the device: 22 (34%) had pure SUI; 66% had MUI. In SUI, 68% were 'dry' on ICIQ median value 4.0 (IQR 2.5-8.5); 88% were dry on 24-h pad test (median 0.0, IQR 0.0-8.5). The "dry rate" was lower in MUI: 36% for ICIQ (median 9.0, IQR 5.0-15.0) and 62% for 24-h pad test (median 6.2, IQR 0.95-19.7). A "good" response on IIQ occurred in 88% of SUI and 69% of MUI.

conclusionThese new data showing strong objective benefits of the continence dish should be further validated by randomized trials, but this information should be made available to women seeking treatment options for SUI/MUI (particularly in view of concerns regarding mesh mid-urethral slings).

Indexed as

Suburethral SlingsUrinary IncontinenceUrinary Incontinence, StressCohort StudiesFemaleHumansProspective StudiesTreatment OutcomeContinence dishStress incontinenceVaginal device

Identifiers

PMID34519843
PMCPMC9119894
OpenAlexW3200506114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.